Cure enters this GSL Season 2 Group A best-of-three with strong recent momentum as a consistent top Terran performer, having advanced deep in prior 2026 events including strong showings against Protoss opponents through precise macro and timing attacks. sOs, returning after limited recent play, has posted uneven results in 2026 qualifiers and group stages, including a prior 0-2 loss to Cure in the same season's round of 12. Head-to-head trends favor Cure in PvT matchups, where his ability to punish early aggression and transition into strong mid-game compositions has repeatedly decided series. Both players' current form, map pool familiarity, and sOs's need to stabilize his Protoss execution against elite Terran pressure shape trader consensus around the series outcome.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วCure – sOs




Moneyline
$110 ปริมาณ
Map 1 Winner
$860 ปริมาณ
Map Handicap
$100 ปริมาณ
Total Games
$100 ปริมาณ
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
ตลาดเปิดเมื่อ: May 19, 2026, 6:00 PM ET
แหล่งข้อมูลการตัดสินผล
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure – sOs




Moneyline
$110 ปริมาณ
Map 1 Winner
$860 ปริมาณ
Map Handicap
$100 ปริมาณ
Total Games
$100 ปริมาณ
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
ตลาดเปิดเมื่อ: May 19, 2026, 6:00 PM ET
แหล่งข้อมูลการตัดสินผล
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure enters this GSL Season 2 Group A best-of-three with strong recent momentum as a consistent top Terran performer, having advanced deep in prior 2026 events including strong showings against Protoss opponents through precise macro and timing attacks. sOs, returning after limited recent play, has posted uneven results in 2026 qualifiers and group stages, including a prior 0-2 loss to Cure in the same season's round of 12. Head-to-head trends favor Cure in PvT matchups, where his ability to punish early aggression and transition into strong mid-game compositions has repeatedly decided series. Both players' current form, map pool familiarity, and sOs's need to stabilize his Protoss execution against elite Terran pressure shape trader consensus around the series outcome.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย